Literature DB >> 1933977

Embolotherapy for small bowel hemorrhage from metastatic renal cell carcinoma: case report.

B Gordon1, S V Lossef, E Jelinger, K H Barth.   

Abstract

Embolization for control of hemorrhage in the small bowel carries a significant risk of bowel infarction. A case is presented where severe gastrointestinal hemorrhage from a hypervascular renal cell carcinoma metastasis to the jejunum was effectively controlled by superselective embolization of mesenteric tumor supply arteries with Gelfoam particles. Adjacent normal mesenteric arteries remained open. It is concluded that in specific instances where direct mesenteric feeders to a tumor can be catheterized, such embolization can be performed safely.

Entities:  

Mesh：

Year:  1991        PMID： 1933977     DOI： 10.1007/bf02578457

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN： 0174-1551            Impact factor:   2.740


  10 in total

1.  Late involvement of the alimentary tract by carcinoma of the kidney.

Authors:  M T KHILNANI; B S WOLF
Journal:  Am J Dig Dis       Date:  1960-06

2.  Solitary jejunal metastasis twenty years after removal of a renal-cell carcinoma; report of a case.

Authors:  A STARR; G M MILLER
Journal:  N Engl J Med       Date:  1952-02-14       Impact factor: 91.245

3.  Malignancy of the kidney, survey of 195 cases.

Authors:  A P GRAHAM
Journal:  J Urol       Date:  1947-07       Impact factor: 7.450

4.  Current concepts in angiographic management of gastrointestinal bleeding.

Authors:  S Kadir; C B Ernst
Journal:  Curr Probl Surg       Date:  1983-05       Impact factor: 1.909

5.  Embolization versus vasopressin infusion in gastrointestinal bleeding.

Authors:  J J Bookstein
Journal:  Cardiovasc Intervent Radiol       Date:  1980       Impact factor: 2.740

6.  Mesenteric angiography in the evaluation of inflammatory and neoplastic disease of the intestine.

Authors:  E Bousen; S R Reuter
Journal:  Radiology       Date:  1966-12       Impact factor: 11.105

7.  Therapeutic embolization of the small-bowel arteries.

Authors:  J C Palmaz; J F Walter; K J Cho
Journal:  Radiology       Date:  1984-08       Impact factor: 11.105

8.  Postembolic colonic infarction.

Authors:  H Rosenkrantz; J J Bookstein; R J Rosen; W B Goff; J F Healy
Journal:  Radiology       Date:  1982-01       Impact factor: 11.105

9.  Therapeutic arterial embolisation: report of five years' experience.

Authors:  D O'Halpin; D Legge; D P MacErlean
Journal:  Clin Radiol       Date:  1984-03       Impact factor: 2.350

10.  Diagnosis and management of massive gastrointestinal bleeding owing to duodenal metastasis from renal cell carcinoma.

Authors:  A Lynch-Nyhan; E K Fishman; S Kadir
Journal:  J Urol       Date:  1987-09       Impact factor: 7.450
  10 in total
  6 in total

1.  Solitary jejunal metastasis from renal cell carcinoma presenting as small bowel obstruction 19 years after nephrectomy.

Authors:  Ibrahim Ismail; Brendon Lange Neuen; Murty Mantha
Journal:  BMJ Case Rep       Date:  2015-09-14

2.  Embolotherapy for massive upper gastrointestinal haemorrhage secondary to metastatic renal cell carcinoma: report of three cases.

Authors:  M A Blake; A Owens; D P O'Donoghue; D P MacErlean
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

Review 3.  Palliative Embolization for Refractory Bleeding.

Authors:  Andrew Niekamp; Rahul A Sheth; Joshua Kuban; Rony Avritscher; Suvranu Ganguli
Journal:  Semin Intervent Radiol       Date:  2017-12-14       Impact factor: 1.513

4.  Duodenal bleeding from metastatic renal cell carcinoma.

Authors:  Tarun Rustagi; Priya Rangasamy; Mark Versland
Journal:  Case Rep Gastroenterol       Date:  2011-04-20

5.  Local recurrence of renal cell carcinoma presented with massive gastrointestinal bleeding: management with renal artery embolization.

Authors:  Donya Farrokh; Masoud Pezeshki Rad; Reihaneh Mortazavi; Reza Akhavan; Bita Abbasi
Journal:  CVIR Endovasc       Date:  2019-03-15

6.  Embolisation of cancer: what is the evidence?

Authors:  J A Goode; M B Matson
Journal:  Cancer Imaging       Date:  2004-09-17       Impact factor: 3.909
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.